Predicting comorbidities in psoriasis using TCM constitution and multimodal data: a prospective cohort study protocol - Top-Institutions - MDSpire

Assessing Comorbidities in Psoriasis Through TCM Constitution and Multimodal Data: A Protocol for a Prospective Cohort Study

  • By

  • Jing Hu

  • Di Long

  • Junchen Chen

  • Meijunzi Luo

  • Rong Zhou

  • Xuanchun Zhang

  • Ziwan Lei

  • Wenyu Deng

  • Yehong Kuang

  • Haizhen Wang

  • July 21, 2026

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    The Second Affiliated Hospital of Hunan University
    The Second Affiliated Hospital of Hunan University

    Changsha, Hunan

    Key Differentiators

    • Dermatology

  • #2

    Xiangya Hospital, Central South University
    Xiangya Hospital, Central South University

    Changsha, Hunan

    Key Differentiators

    • Dermatology

  • #3

    The Affiliated Hospital of Yan'an University
    The Affiliated Hospital of Yan'an University

    Yan'an, Shaanxi

    Key Differentiators

    • Dermatology

Original Source(s)

Predicting comorbidities in psoriasis using TCM constitution and multimodal data: a prospective cohort study protocol

  • by Jing Hu, Di Long, Junchen Chen, Meijunzi Luo, Rong Zhou, Xuanchun Zhang, Ziwan Lei, Wenyu Deng, Yehong Kuang, Haizhen Wang

  • July 21, 2026

Related Content

FDA Approves Pediatric Risankizumab

Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.

Informatics-Based Psychotherapeutic and Psychiatric Interventions in Dermatology: Scoping Review of Impacts on Skin Disease Severity and Mental Health Outcomes

Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis